{"id":"https://openalex.org/W4362494137","doi":"https://doi.org/10.1158/1535-7163.22500252","title":"Supplementary Figures 1 - 6 from Therapeutic Potential of the Poly(ADP-ribose) Polymerase Inhibitor Rucaparib for the Treatment of Sporadic Human Ovarian Cancer","display_name":"Supplementary Figures 1 - 6 from Therapeutic Potential of the Poly(ADP-ribose) Polymerase Inhibitor Rucaparib for the Treatment of Sporadic Human Ovarian Cancer","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362494137","doi":"https://doi.org/10.1158/1535-7163.22500252"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22500252","doi":"https://doi.org/10.1158/1535-7163.22500252","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22500252","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1535-7163.22500252","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042074529","display_name":"Maike Ihnen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maike Ihnen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036502346","display_name":"Christine zu Eulenburg","orcid":"https://orcid.org/0000-0001-9365-5548","observed_orcids":["https://orcid.org/0000-0001-9365-5548"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christine zu Eulenburg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102966006","display_name":"Teodora R. Kolarova","orcid":"https://orcid.org/0000-0001-8093-0774","observed_orcids":["https://orcid.org/0000-0001-8093-0774"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Teodora Kolarova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Jing Wei Qi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing Wei Qi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064453119","display_name":"Kanthinh Manivong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kanthinh Manivong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042786886","display_name":"Meenal Chalukya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meenal Chalukya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066999153","display_name":"Judy Dering","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Judy Dering","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Lee Anderson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lee Anderson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110850","display_name":"Charles Ginther","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charles Ginther","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110349434","display_name":"Alexandra Meuter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexandra Meuter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068044534","display_name":"Boris J. N. Winterhoff","orcid":"https://orcid.org/0000-0002-1334-8650","observed_orcids":["https://orcid.org/0000-0002-1334-8650"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Boris Winterhoff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001000201","display_name":"Si\u00e2n Jones","orcid":"https://orcid.org/0000-0002-2374-8391","observed_orcids":["https://orcid.org/0000-0002-2374-8391"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Si\u00e2n Jones","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006560755","display_name":"Victor E. Velculescu","orcid":"https://orcid.org/0000-0003-1195-438X","observed_orcids":["https://orcid.org/0000-0003-1195-438X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victor E. Velculescu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001426056","display_name":"Natarajan Venkatesan","orcid":"https://orcid.org/0009-0008-1030-1532","observed_orcids":["https://orcid.org/0009-0008-1030-1532"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Natarajan Venkatesan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088601110","display_name":"Hong-Mei Rong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hong-Mei Rong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045104906","display_name":"Sugandha Dandekar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sugandha Dandekar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011864225","display_name":"Nitin Udar","orcid":"https://orcid.org/0000-0001-8533-9190","observed_orcids":["https://orcid.org/0000-0001-8533-9190"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nitin Udar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047836442","display_name":"Fritz J\u00e4nicke","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fritz J\u00e4nicke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088143958","display_name":"Gerrit Los","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerrit Los","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015491002","display_name":"Dennis J. Slamon","orcid":"https://orcid.org/0000-0002-6330-498X","observed_orcids":["https://orcid.org/0000-0002-6330-498X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dennis J. Slamon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5062837404","display_name":"Gottfried E. Konecny","orcid":"https://orcid.org/0000-0001-6083-657X","observed_orcids":["https://orcid.org/0000-0001-6083-657X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gottfried E. Konecny","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rucaparib","display_name":"rucaparib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.9240000247955322},{"id":"https://openalex.org/keywords/sporadic-ovarian-cancer","display_name":"sporadic ovarian cancer","score":0.9520000219345093},{"id":"https://openalex.org/keywords/brca1","display_name":"BRCA1","score":0.9480000138282776},{"id":"https://openalex.org/keywords/brca2","display_name":"BRCA2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cpg-islands","display_name":"CpG islands","score":0.8840000033378601},{"id":"https://openalex.org/keywords/dna-methylation","display_name":"DNA methylation","score":0.734000027179718},{"id":"https://openalex.org/keywords/anchorage-independent-growth","display_name":"anchorage-independent growth","score":0.8899999856948853},{"id":"https://openalex.org/keywords/ovarian-cancer-cell-lines","display_name":"ovarian cancer cell lines","score":0.9580000042915344},{"id":"https://openalex.org/keywords/drug-combination-effects","display_name":"drug combination effects","score":0.6660000085830688},{"id":"https://openalex.org/keywords/topotecan","display_name":"topotecan","score":0.9929999709129333},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.39399999380111694}],"concepts":[{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.6441776752471924},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.511625349521637},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4271659255027771},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39179450273513794},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35368192195892334},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35247641801834106},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3420789837837219},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.284088134765625},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.27728280425071716},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.24400115013122559},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.22092348337173462}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.22500252","doi":"https://doi.org/10.1158/1535-7163.22500252","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22500252","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.22500252.v1","doi":"https://doi.org/10.1158/1535-7163.22500252.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22500252.v1","pdf_url":"https://aacr.figshare.com/ndownloader/files/39959529","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22500252","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figures_1_-_6_from_Therapeutic_Potential_of_the_Poly_ADP-ribose_Polymerase_Inhibitor_Rucaparib_for_the_Treatment_of_Sporadic_Human_Ovarian_Cancer/22500252","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22500252","doi":"https://doi.org/10.1158/1535-7163.22500252","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22500252","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362494137.pdf","grobid_xml":"https://content.openalex.org/works/W4362494137.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2137760882","https://openalex.org/W4362493018","https://openalex.org/W2775005680","https://openalex.org/W6921073326","https://openalex.org/W2022783349","https://openalex.org/W2809462886","https://openalex.org/W2740632734","https://openalex.org/W2770781233","https://openalex.org/W2588907697","https://openalex.org/W2768427041"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"603K,":[3],"Supplemental":[4,22,49,114],"Figure":[5,23,50,70,82,115],"S1:":[6],"Gene":[7],"maps":[8],"of":[9,54,74,91,124],"the":[10,36,55,62,78,103,136],"BRCA1":[11],"(A)":[12],"and":[13,95,128,147],"BRCA2":[14],"(B)":[15],"CpG":[16],"islands":[17],"examined":[18],"with":[19],"bisulfite":[20],"pyrosequencing.":[21],"S2:":[24],"Anchorage":[25],"independent":[26],"growth":[27],"inhibition":[28],"at":[29,142],"1\u03bcM":[30],"rucaparib":[31,148],"in":[32,46],"soft":[33,47],"agar.":[34,48],"Of":[35],"39":[37],"tested":[38],"ovarian":[39],"cancer":[40],"cell":[41,56,93,126],"lines":[42],"22":[43],"formed":[44],"colonies":[45],"S3:":[51],"Microarray":[52],"hybridizations":[53],"line":[57],"panel":[58],"were":[59],"performed":[60],"using":[61],"Agilent":[63],"Whole":[64],"Human":[65],"Genome":[66],"4X44K":[67],"array":[68],"chip.Supplemental":[69],"S4:":[71],"Chemical":[72],"structures":[73],"compounds":[75],"used":[76],"for":[77,89,122],"drug":[79,96,104,129,151],"interaction":[80],"studies.Supplemental":[81],"S5:":[83],"A":[84,117],"multivariate":[85,118],"ANOVA":[86,119],"model":[87,120],"(accounting":[88,121],"type":[90,123],"chemotherapy,":[92,125],"line,":[94,127],"concentration":[97,130],"as":[98,131],"single":[99,132],"factors)":[100,133],"indicates":[101,134],"that":[102,135],"combination":[105,138],"effects":[106],"differed":[107],"significantly":[108],"between":[109],"individual":[110],"chemotherapeutic":[111],"agents":[112],"(P=0.010).":[113],"S6:":[116],"best":[137],"effect":[139],"was":[140],"achieved":[141],"lower":[143],"topotecan":[144],"(0.031":[145],"\u03bcM)":[146,150],"(0.625":[149],"concentrations":[152],"(P=0.018).":[153]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}